Equities Analysts Offer Predictions for ZVRA FY2029 Earnings

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - Stock analysts at Roth Capital lowered their FY2029 earnings estimates for Zevra Therapeutics in a report issued on Tuesday, March 11th. Roth Capital analyst J. Aschoff now anticipates that the company will post earnings per share of $2.05 fo